Cargando…

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral Spike vaccines

Mostrar otras versiones (1)

The SARS-CoV-2 Spike glycoprotein mediates virus entry and is a major target for neutralizing antibodies. All current vaccines are based on the ancestral Spike with the goal of generating a protective neutralizing antibody response. Several novel SARS-CoV-2 variants with multiple Spike mutations hav...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shen, Xiaoying, Tang, Haili, McDanal, Charlene, Wagh, Kshitij, Fischer, Will, Theiler, James, Yoon, Hyejin, Li, Dapeng, Haynes, Barton F., Sanders, Kevin O., Gnanakaran, Sandrasegaram, Hengartner, Nick, Pajon, Rolando, Smith, Gale, Dubovsky, Filip, Glenn, Gregory M., Korber, Bette, Montefiori, David C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cold Spring Harbor Laboratory 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7852228/ https://www.ncbi.nlm.nih.gov/pubmed/33532764 http://dx.doi.org/10.1101/2021.01.27.428516

Ejemplares similares

SARS-CoV-2 variant B.1.1.7 is susceptible to neutralizing antibodies elicited by ancestral spike vaccines
por: Shen, Xiaoying, et al.
Publicado: (2021)

Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
por: Shen, Xiaoying, et al.
Publicado: (2021)

Tracking Changes in SARS-CoV-2 Spike: Evidence that D614G Increases Infectivity of the COVID-19 Virus
por: Korber, Bette, et al.
Publicado: (2020)

SARS-CoV-2 variant transition dynamics are associated with vaccination rates, number of co-circulating variants, and convalescent immunity
por: Beesley, Lauren J., et al.
Publicado: (2023)

A single, continuous metric to define tiered serum neutralization potency against HIV
por: Hraber, Peter, et al.
Publicado: (2018)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
por: Nguyen, Kien, et al.
Publicado: (2021)

Exploring the Role of Glycans in the Interaction of SARS-CoV-2 RBD and Human Receptor ACE2
por: Nguyen, Kien, et al.
Publicado: (2021)

HIV-1 and SARS-CoV-2: Patterns in the evolution of two pandemic pathogens
por: Fischer, Will, et al.
Publicado: (2021)

Quantification of the Resilience and Vulnerability of HIV-1 Native Glycan Shield at Atomistic Detail
por: Chakraborty, Srirupa, et al.
Publicado: (2020)

Polyvalent vaccine approaches to combat HIV‐1 diversity
por: Korber, Bette, et al.
Publicado: (2017)

The SARS-CoV-2 Spike variant D614G favors an open conformational state
por: Mansbach, Rachael A., et al.
Publicado: (2021)

The SARS-CoV-2 Spike Variant D614G Favors an Open Conformational State
por: Mansbach, Rachael A., et al.
Publicado: (2021)

Graph‐based optimization of epitope coverage for vaccine antigen design
por: Theiler, James, et al.
Publicado: (2017)

Epigraph: A Vaccine Design Tool Applied to an HIV Therapeutic Vaccine and a Pan-Filovirus Vaccine
por: Theiler, James, et al.
Publicado: (2016)

D614G Spike Mutation Increases SARS CoV-2 Susceptibility to Neutralization
por: Weissman, Drew, et al.
Publicado: (2021)

Longitudinal Antigenic Sequences and Sites from Intra-Host Evolution (LASSIE) Identifies Immune-Selected HIV Variants
por: Hraber, Peter, et al.
Publicado: (2015)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of Two Validated SARS-CoV-2 Pseudovirus Neutralization Assays for COVID-19 Vaccine Evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

Calibration of two validated SARS-CoV-2 pseudovirus neutralization assays for COVID-19 vaccine evaluation
por: Huang, Yunda, et al.
Publicado: (2021)

A Mechanistic Understanding of Allosteric Immune Escape Pathways in the HIV-1 Envelope Glycoprotein
por: Sethi, Anurag, et al.
Publicado: (2013)

Impact of mutations near the SARS-CoV-2 furin-cleavage site on viral infectivity
por: Nguyen, Kien, et al.
Publicado: (2022)

Genetic Signatures in the Envelope Glycoproteins of HIV-1 that Associate with Broadly Neutralizing Antibodies
por: Gnanakaran, S., et al.
Publicado: (2010)

Booster of mRNA-1273 Strengthens SARS-CoV-2 Omicron Neutralization
por: Doria-Rose, Nicole A., et al.
Publicado: (2021)

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
por: Haynes, Barton F., et al.
Publicado: (2022)

Structural basis for breadth development in the HIV-1 V3-glycan targeting DH270 antibody clonal lineage
por: Henderson, Rory, et al.
Publicado: (2023)

Effect of Glycosylation on an Immunodominant Region in the V1V2 Variable Domain of the HIV-1 Envelope gp120 Protein
por: Tian, Jianhui, et al.
Publicado: (2016)

Essential Dynamics that Drive Sars-Cov-2 Spike Conformational Changes
por: Chakraborty, Srirupa, et al.
Publicado: (2021)

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
por: Bricault, Christine A., et al.
Publicado: (2019)

HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
por: Bricault, Christine A., et al.
Publicado: (2019)

Mapping SARS-CoV-2 antigenic relationships and serological responses
por: Wilks, Samuel H., et al.
Publicado: (2023)

Potential of conventional & bispecific broadly neutralizing antibodies for prevention of HIV-1 subtype A, C & D infections
por: Wagh, Kshitij, et al.
Publicado: (2018)

P04-54 LB. Genetic signature analysis identifies the CD4i region of gp120 as a determinant of broadly NAb responses in HIV-1-infected individuals
por: Gnanakaran, G, et al.
Publicado: (2009)

A coarse-grained model for synergistic action of multiple enzymes on cellulose
por: Asztalos, Andrea, et al.
Publicado: (2012)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Optimal Combinations of Broadly Neutralizing Antibodies for Prevention and Treatment of HIV-1 Clade C Infection
por: Wagh, Kshitij, et al.
Publicado: (2016)

A Signature in HIV-1 Envelope Leader Peptide Associated with Transition from Acute to Chronic Infection Impacts Envelope Processing and Infectivity
por: Asmal, Mohammed, et al.
Publicado: (2011)

Formation of $^{117}In-H$ pairs after annealing of GaN implanted with $^{117}Cd(^{117}In)$
por: Dietrich, M, et al.
Publicado: (2001)

Decay study of the $^{117}$Cs and $^{117}$Xe nuclei
por: Marguier, G, et al.
Publicado: (1985)

Coping with Viral Diversity in HIV Vaccine Design: A Response to Nickle et al
por: Fischer, Will, et al.
Publicado: (2008)

Emergence of SARS-CoV-2 through recombination and strong purifying selection
por: Li, Xiaojun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_2o7sb4d3u3gscjrcpcffoo5ooq